跳至主要内容
临床试验/NCT02965261
NCT02965261已完成1 期

An Open Label, Randomized, 2-Period, 2-Treatment,2-Sequence, Crossover, Single-Dose BE Study of Fluoxetine Tablets 20 mg [Torrent,India] Versus Sarafem 20 mg Tablet [ Warner Chilcott LLC, USA] in Healthy Subjects-Fasted Condition.

Torrent Pharmaceuticals Limited0 个研究点目标入组 26 人开始时间: 2013年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
26
主要终点
Cmax

研究概览

简要总结

Subjects to compare the single dose bioavailability of Torrent's Fluoxetine Tablets 20 mg and Sarafem® 20 mg Tablets of Warner Chilcott LLC, USA. Dosing periods of studies were separated by a washout period of 35 days.

详细描述

An Open Label, Randomized, 2-period, 2- Treatment, 2-Sequence, Crossover, Single-dose Bioequivalence Study of Fluoxetine Tablets containing Fluoxetine 20 mg ( Test Formulation, Torrent Pharmaceutical Ltd., India) Versus Sarafem® 20 mg Tablets containing Fluoxetine 20 mg (Reference , Warner Chilcott LLC, USA) in Healthy Human Volunteers Under Fasting Condition.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Sex: male
  • Age: 18-45 years (inclusive both)
  • Volunteer with BMI of 18.5-27 (inclusive both) kg/m2 with minimum of 50 kg weight.
  • Healthy and willing to participate in the study.
  • Volunteer willing to provide written informed consent.
  • Non-smokers or smoker who smokes less than 10 cigarettes per day.

排除标准

  • Inability to communicate or co-operate.
  • Volunteers suffering from any chronic illness such as arthritis, asthma etc.
  • History of pre-existing bleeding disorder.
  • Clinically relevant abnormalities in the results of the laboratory screening evaluation.
  • Clinically significant abnormal ECG or Chest X-ray.
  • HIV, HCV, HBsAg positive volunteers.
  • History of significant blood loss due to any reason, including blood donation in the past 3 months.
  • Participation in any study within past 3 months,
  • History of alcohol or drug abuse.
  • History of consumption of prescribed medication since last 14days or OTC medication/ herbal remedies since last 7 days before beginning of the study. Positive to Breath alcohol test.
  • Positive to breath alcohol test.
  • Volunteer found to be positive for Opiate, tetra hydrocannabinol, amphetamine, barbiturates, benzodiazepines, Cocaine positive volunteers based on urine test.
  • Systolic blood pressure less than 100 mmHg or more than 139 mmHg and diastolic blood pressure less than 60 mm Hg or more than 89 mm Hg.
  • Pulse rate less than 60/minute or more than 100/minute.
  • Oral temperature less than 95°F or more than 98.9°F.
  • Respiratory rate less than 10/minute or more than 20/minute.
  • History of allergy to the test drug or any drug chemically similar to the drug under investigation.
  • Recent History of kidney or liver dysfunction.
  • Volunteers suffering from any psychiatric (acute or chronic) disorder.
  • Existence of any surgical or medical condition, which, in the judgment of the Chief Investigator and/or clinical investigator/physician, might interfere with the absorption; distribution,· metabolism or excretion of the drug or likely to compromise the safety of Volunteers.

研究组 & 干预措施

Test

Experimental

Torrent's Fluoxetine Tablets 20 mg

干预措施: Torrent's Fluoxetine Tablets (Drug)

Reference

Active Comparator

Warner Chilcott LLC's Sarafem® Tablet 20 mg

干预措施: Warner Chilcott LLC Sarafem Tablets (Drug)

结局指标

主要结局

Cmax

时间窗: pre-dose to 72 hours post-dose

AUC

时间窗: pre-dose to 72 hours post-dose

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验